This article explores why leadership is essential in biosimilar manufacturing and how it influences the success of these complex products.
Healthcare Health/Fitness
BuildMyHealth: Navigating the GLP-1 Market with Dr. Jonathan Kaplan's Vision
The market for GLP-1 (glucagon-like peptide-1) receptor agonists is quickly becoming a profitable investment option. Despite these medications' promising efficacy and expanding indications, the market faces significant challenges that need innovative solutions. Dr. Jonathan Kaplan, a renowned plastic surgeon and entrepreneur, has strategically positioned his company, BuildMyHealth, to tackle these obstacles and take advantage of the vast opportunities in the GLP-1 market.
US FTC to File Lawsuit Against 3 Biggest Prescription Drug Middlemen Over Insulin Prices: Report
The US Federal Trade Commission (FTC) is reportedly filing a lawsuit against the three biggest prescription drug middlemen over insulin prices.
Ozempic, Wegovy Weight Loss Drugs See High Dropout Rate Within Two Years Over Cost-Effectiveness Concerns
A US pharmacy study found that most patients prescribed Wegovy or Ozempic for weight loss discontinue their use within two years.
Credit Scores Can Also Be an Early Warning Sign of Cognitive Decline, Research Finds
A new study found that credit scores, which measure a person's capacity to pay back loans, may also serve as an early indicator of cognitive deterioration.
Latest News
An alarming investigation has revealed that tampons contain toxic metals, including dangerous levels of arsenic, chromium, and lead, with all 16 tested metals detected in at least one product.
There are not many things as heartwarming as watching a playground full of children joyfully running, jumping, climbing, smiling, laughing, and playing. Unfortunately, for more than 3 million children who are diagnosed and treated for scoliosis each year, running and playing are often limited, and 63% of them fight pain daily.
President Joe Biden and Senator Bernie Sanders have urged Novo Nordisk and Eli Lilly to lower the prices of their popular weight loss drugs.
Moderna received $176 million from the US government to fast-track the development of its bird flu vaccine, following the spread of the H5N1 virus in dairy herds across multiple states.
Community Health Systems expands its partnership with Mark Cuban Cost Plus Drugs, enabling 71 hospitals to access a wider range of generic medicines.
In response to the critical limitations of traditional ventilators, VentSafe has developed an ultra-high-frequency ventilation system that operates at a rate ten times faster than existing high-frequency technologies.
As drugs for diabetes and weight loss, such as Ozempic and Wegovy, have surged in popularity, so has the issue of fake versions entering the market.
Prescription drug prices in the US have reportedly climbed over the past decade, with a rate far surpassing inflation.
The US Food and Drug Administration (FDA) urged drugmakers and medical device manufacturers to improve racial and cultural diversity in clinical trials.
